Seastar medical targets NEUTRALIZE-AKI enrollment completion around year-end or Q1 2027 as QUELIMMUNE adoption reaches 20 hospitals (NASDAQ:ICU)
· seekingalpha.com
SeaStar Medical (ICU) Q2 2026 earnings call: QUELIMMUNE growth, CMS ICD-10 codes Oct 1, NEUTRALIZE-AKI enrollment and cash burn—read now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...